[Why the cardiologists should be interested in lipids?]

Area of Science:

• Cardiology
• Lipidology
• Cardiovascular Disease Research

Background:

• Blood lipid levels are established risk factors for coronary heart disease (CHD) and predict mortality.
• Lipid accumulation is central to the pathophysiology of ischemic heart disease, forming atherosclerotic plaques.
• Lipid abnormalities are highly prevalent in patients with existing CHD, often detectable and manageable.

Purpose of the Study:

• To outline the critical reasons for cardiologists' engagement with lipid management.
• To emphasize the role of lipids in cardiovascular disease pathogenesis and patient outcomes.
• To highlight the importance of lipid-lowering therapies in clinical cardiology practice.

Main Methods:

• Review of epidemiological evidence linking lipid levels to cardiovascular risk.
• Discussion of the physiopathologic role of lipids in atherosclerosis and plaque instability.
• Analysis of clinical trial data and ongoing research in lipid-lowering therapies.

Main Results:

• Lipid reduction is associated with atherosclerosis regression and decreased ischemic events.
• Lipid-lowering therapy demonstrates significant benefits, particularly in patients with established CHD.
• Emerging lipid-lowering agents offer new therapeutic possibilities and short-term symptom improvement.

Conclusions:

• Cardiologists play a pivotal role in lipid management, influencing patient outcomes significantly.
• Ongoing research and clinical trials are essential for refining treatment guidelines and strategies.
• Addressing patient lipid profiles is a fundamental responsibility of cardiologists, regardless of their personal interest.